Announcements Trials
Browse Landscape

Phase

Phase 4 6Phase 3 3Phase 2 3

Status

Completed 2Unknown 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Conditions

Pain 4Neoplasms 3Cancer Pain 3Pain, Postoperative 1Non Cancer Pain 1Multiple Myeloma 1Malignant Neoplasms of Female Genital Organs 1Lymphoma 1

Interventions

Paclitaxel 20Gemcitabine 16Dexamethasone 16Bevacizumab 16Docetaxel 15Oxaliplatin 14Cyclophosphamide 13Carboplatin 12Capecitabine 12Sorafenib 11Fluorouracil 11Leucovorin 10Cisplatin 10pembrolizumab 9Pemetrexed 9Epoetin Alfa 9venetoclax 8Prednisone 8Fentanyl 8Drug Therapy 8Doxorubicin 8atezolizumab 7Rivaroxaban 7Rituximab 7Darbepoetin alfa 7Anastrozole 7Panitumumab 6Ondansetron 6Morphine 6Irinotecan 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Neoplasms × Oxycodone × Clear all
NCT01885182 2019-10-04

Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer Pain

Mundipharma (China) Pharmaceutical Co. Ltd

Phase 3 Completed
232 enrolled 16 charts

Neoplasms, Pain

NCT01675622 2018-05-21

Immediate-Release Oxycodone Capsules Study in Cancer Pain

Mundipharma (China) Pharmaceutical Co. Ltd

Phase 3 Completed
242 enrolled 20 charts

Cancer Pain, Neoplasms

NCT02084355 2014-03-12

Study of Opioid Rotation Versus Opioid Escalation in Patients With Moderate to Severe Cancer Pain

Gyeongsang National University Hospital

Phase 3 Unknown
136 enrolled

Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡